Intraperitoneal Dexmedetomidine Versus Magnesium as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Bupivacaine 100 mg + dexmedetomidine 1 µg/kg: 20 ml bupivacaine + 1 µg/kg dexmedetomidine . The total volume will be adjusted to 50 mL with saline.
Bupivacaine 100 mg + magnesium sulphate 50 mg/kg: 20 ml bupivacaine + 50 mg/kg magnesium sulphate . The total volume will be adjusted to 50 mL with saline.
Study summary
Although both dexmedetomidine and magnesium sulphate have been individually evaluated as adjuvants to local anesthetics, direct comparisons between the two agents in intraperitoneal instillation during laparoscopic cholecystectomy remain limited. Understanding their relative efficacy and safety could provide valuable guidance for optimizing perioperative analgesia in these patients.
Eligibility
Primary outcome measure(s)
- Postoperative pain scores (VAS) — postoperative day 1
at rest , at movement - Quality of recovery — postoperative day 1
QoR-15 questionnaire
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Alexandria University | Alexandria | Egypt | Recruiting |
More Alexandria University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07693621 on ClinicalTrials.gov ↗ ← All trials in Egypt